Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rui Gou

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Journal of Translational Medicine|June 6, 2026
RAD21 regulation of the enhancer-promoter chromatin loop of RAD51 promotes PARPi resistance in ovarian cancerRui Gou, Xiaohong Chang, Hongyan Cheng, et al.
Molecules (Basel, Switzerland)|July 27, 2022
Maleimide-Functionalized Liposomes: Prolonged Retention and Enhanced Efficacy of Doxorubicin in Breast Cancer with Low Systemic ToxicityChuane Tang, Dan Yin, Tianya Liu, et al.
American Journal of Translational Research|October 12, 2020
Identification of KIF23 as a prognostic signature for ovarian cancer based on large-scale sampling and clinical validationYuexin Hu, Mingjun Zheng, Caixia Wang, et al.
Genomics|April 12, 2021
Identification of a five-gene signature of the RGS gene family with prognostic value in ovarian cancerYuexin Hu, Mingjun Zheng, Shuang Wang, et al.
Journal of Cancer|October 18, 2021
Keratin 80 regulated by miR-206/ETS1 promotes tumor progression via the MEK/ERK pathway in ovarian cancerOuxuan Liu, Caixia Wang, Shuang Wang, et al.
Aging|July 2, 2019
Integrated multi-omics analysis of genomics, epigenomics, and transcriptomics in ovarian carcinomaMingjun Zheng, Yuexin Hu, Rui Gou, et al.
Frontiers in Oncology|July 19, 2021
PGK1 Is a Key Target for Anti-Glycolytic Therapy of Ovarian Cancer: Based on the Comprehensive Analysis of Glycolysis-Related GenesRui Gou, Yuexin Hu, Ouxuan Liu, et al.
Angewandte Chemie (International Ed. in English)|February 14, 2020
A Modular Synthetic Strategy for Functional MacrocyclesKaidi Xu, Zhi-Yuan Zhang, Chengmao Yu, et al.
Journal of Cellular and Molecular Medicine|January 30, 2020
Identification of immune-enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinomaMingjun Zheng, Yuexin Hu, Rui Gou, et al.
Cancer Cell International|September 3, 2020
Down-regulation of TRIB3 inhibits the progression of ovarian cancer via MEK/ERK signaling pathwayShuang Wang, Caixia Wang, Xiao Li, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Journal of Translational Medicine|June 6, 2026
RAD21 regulation of the enhancer-promoter chromatin loop of RAD51 promotes PARPi resistance in ovarian cancerRui Gou, Xiaohong Chang, Hongyan Cheng, et al.
Molecules (Basel, Switzerland)|July 27, 2022
Maleimide-Functionalized Liposomes: Prolonged Retention and Enhanced Efficacy of Doxorubicin in Breast Cancer with Low Systemic ToxicityChuane Tang, Dan Yin, Tianya Liu, et al.
American Journal of Translational Research|October 12, 2020
Identification of KIF23 as a prognostic signature for ovarian cancer based on large-scale sampling and clinical validationYuexin Hu, Mingjun Zheng, Caixia Wang, et al.
Genomics|April 12, 2021
Identification of a five-gene signature of the RGS gene family with prognostic value in ovarian cancerYuexin Hu, Mingjun Zheng, Shuang Wang, et al.
Journal of Cancer|October 18, 2021
Keratin 80 regulated by miR-206/ETS1 promotes tumor progression via the MEK/ERK pathway in ovarian cancerOuxuan Liu, Caixia Wang, Shuang Wang, et al.
Aging|July 2, 2019
Integrated multi-omics analysis of genomics, epigenomics, and transcriptomics in ovarian carcinomaMingjun Zheng, Yuexin Hu, Rui Gou, et al.
Frontiers in Oncology|July 19, 2021
PGK1 Is a Key Target for Anti-Glycolytic Therapy of Ovarian Cancer: Based on the Comprehensive Analysis of Glycolysis-Related GenesRui Gou, Yuexin Hu, Ouxuan Liu, et al.
Angewandte Chemie (International Ed. in English)|February 14, 2020
A Modular Synthetic Strategy for Functional MacrocyclesKaidi Xu, Zhi-Yuan Zhang, Chengmao Yu, et al.
Journal of Cellular and Molecular Medicine|January 30, 2020
Identification of immune-enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinomaMingjun Zheng, Yuexin Hu, Rui Gou, et al.
Cancer Cell International|September 3, 2020
Down-regulation of TRIB3 inhibits the progression of ovarian cancer via MEK/ERK signaling pathwayShuang Wang, Caixia Wang, Xiao Li, et al.
Pageof 5